文献速递神经肿瘤

肢端肥大症患者经蝶术后缓解预后因素

Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
PubMed 文献 · World Neurosurg · 2020-12-09

该回顾性研究纳入2003年至2019年在Songklanagarind医院接受经蝶手术的51例生长激素(GH)分泌型垂体腺瘤患者,按2000和2010年共识标准判定末次随访缓解。微腺瘤与大腺瘤术后缓解率分别为100%和43.75%,术前IGF-1指数≥2.5与Knosp分级3-4级为不缓解的独立预后因素。

要点

  • 微腺瘤经蝶术后缓解率100%,大腺瘤为43.75%。
  • 术前IGF-1指数≥2.5与Knosp 3-4级均与不缓解显著相关。
  • 同时具备两项不良因素者从未缓解,需联合手术、药物及可能放疗。

核心结论

  • 术前IGF-1指数≥2.5和Knosp分级3-4级是决定经蝶术后缓解结局的重要预后因素。
  • 同时具备两项不良预后因素的患者应积极联合手术、药物及可能的放疗以优化疾病控制。

研究设计与样本

  • 单中心回顾性研究,纳入2003年1月至2019年12月在Songklanagarind医院接受经蝶手术切除肿瘤的GH分泌型垂体腺瘤患者51例。
  • 主要结局为末次随访时按2000和2010年共识标准判定的疾病缓解,采用logistic回归分析各因素与缓解的关联。

主要发现

  • GH分泌型垂体微腺瘤和大腺瘤经蝶术后缓解率分别为100%和43.75%。
  • 多因素分析显示术前IGF-1指数≥2.5与不缓解显著相关(P < 0.001)。
  • 多因素分析显示Knosp分级3-4级与不缓解显著相关(P = 0.012)。
  • 同时具备两项因素者治疗后从未缓解,两项均无者术后缓解率为87.5%。
  • 6例再次手术患者中4例(66.7%)获得缓解。

关键数值与推荐

  • 缓解判定采用2000和2010年共识标准。
  • 术前IGF-1指数≥2.5:多因素分析与不缓解相关,P < 0.001。
  • Knosp分级3-4级:多因素分析与不缓解相关,P = 0.012。
  • 微腺瘤缓解率100%,大腺瘤缓解率43.75%。
  • 两项因素均无者术后缓解率87.5%。

临床怎么用

  • 术前可用IGF-1指数≥2.5和Knosp分级3-4级识别经蝶术后可能不缓解的肢端肥大症患者。
  • 对同时具备两项不良因素者,应考虑手术、药物及可能的放疗联合方案以优化疾病控制。
  • 对术后未缓解者,再次手术可使部分患者(本组66.7%)获得缓解。

局限性

  • 为单中心回顾性研究,样本量仅51例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acromegaly is a rare, chronic disorder that mostly results from growth hormone (GH)-secreting pituitary adenoma. Transsphenoidal surgery is the first-line treatment of this adenoma. This study aimed to identify factors associated with remission outcome in patients with GH-secreting pituitary adenomas following transsphenoidal surgery. METHODS: Patients with GH-secreting pituitary adenomas who underwent transsphenoidal surgery for tumor removal at Songklanagarind Hospital between January 2003 and December 2019 were retrospectively reviewed. The primary outcome was the remission of disease at the last follow-up using 2000 and 2010 consensus criteria. Using logistic regression analysis, various factors were analyzed for association with disease remission outcome. RESULTS: This study included 51 patients. The remission rate of GH-secreting pituitary microadenomas and macroadenomas following transsphenoidal surgery were 100% and 43.75%, respectively. Multivariate analysis showed that preoperative insulin-like growth factor 1 index ≥2.5 and Knosp classification grade 3-4 were significantly associated with nonremission outcome (P < 0.001 and P = 0.012, respectively). Patients with both of these factors had poor outcomes and never achieved remission after treatment, while patients with neither of these factors had high remission rates (87.5%) following surgery. Four of 6 (66.7%) patients who underwent repeat surgery gained remission. CONCLUSIONS: Preoperative insulin-like growth factor 1 index ≥2.5 and Knosp classification grade 3-4 were important prognostic factors that determined remission outcome after treatment. Patients who have both of these poor prognostic factors should be aggressively treated with surgery, medication, and probably radiation to optimally control the disease.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Taweesomboonyat C, Oearsakul T. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery. World Neurosurg. 2020. PMID: 33309643. doi:10.1016/j.wneu.2020.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。